KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:待检查 入排置信度 0.99

Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.

Heinz Lenz, Hiroyuki Arai, Andrew Elliott, Yan Yang, Alex Farrell, Joshua Millstein, Fang-Shu Ou, Federico Innocenti, Jingyuan Wang, Francesca Battaglin, Priya Jayachandran, Sandra Algaze, Shivani Soni, Wu Zhang, Richard M Goldberg, Michael Hall, Aaron Scott, Jimmy Hwang, Emil Lou, Benjamin Weinberg, John L Marshall, Sanjay Goel, Joanne Xiu, W Michael Korn, Alan Venook

Res Sq rs.3.rs-10164107

PMID42427862
PMCIDPMC13345522
DOI10.21203/rs.3.rs-10164107/v1
发表日期2026-07-10
入排依据:记录类型属于综述、Meta 分析、社论、评论、病例或指南。
入排复审未纳入:记录类型属于综述、Meta 分析、社论、评论、病例或指南。
摘要

摘要

Endocytosis regulates receptor trafficking and signaling, yet its role in colorectal cancer (CRC) remains unclear. We analyzed transcriptomic data from 15,025 CRC tumors to evaluate gene expression in clathrin-mediated endocytosis (CME) and the endosomal sorting complexes required for transport (ESCRT) pathway. Pathway-level signatures were compared across consensus molecular subtypes (CMS) and examined in relation to oncogenic signaling programs, while individual endocytosis-related genes were evaluated for associations with clinical outcomes in an independent randomized trial cohort. Expression of CME and ESCRT pathways varied by CMS, with the highest expression in CMS4 and the lowest in CMS3. Endocytosis signatures correlated with multiple oncogenic signaling pathways, including MAPK, TGF-β, WNT, PI3K, NOTCH, and angiogenesis, suggesting broad links between endocytic activity and tumor biology. In the randomized phase III CALGB/SWOG 80405 trial, low expression of AP2M1-a core adaptor in the CME complex-was significantly associated with longer overall survival and progression-free survival in patients treated with anti-EGFR agents, but not in those receiving anti-VEGF agents. These findings suggest that endocytic trafficking may be associated with oncogenic signaling and differential therapeutic benefit in patients with metastatic CRC. The endocytosis pathway reflects biologically relevant heterogeneity in CRC and may help guide therapeutic stratification.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。